MedPath

Acupoint Stimulation Improves Fatigue and Sleep Quality in Patients With Postdialysis

Not Applicable
Completed
Conditions
Hemodialysis
Interventions
Device: Acupoint stimulation
Device: Acupoint stimulation(placebo)
Registration Number
NCT06028685
Lead Sponsor
Taipei Veterans General Hospital, Taiwan
Brief Summary

Hemodialysis is a necessary treatment to prolong the lives of patients with end-stage kidney disease. However, long-term dialysis can lead to fatigue and decreased sleep quality. Acupoint stimulation can regulate meridians and improve physical function. Nevertheless, the effectiveness of low-level laser stimulation on fatigue and sleep quality in hemodialysis patients remains unclear.

This study is designed to use low-level laser stimulation as an intervention measure to evaluate its effectiveness in improving fatigue and sleep quality in hemodialysis patients.

Detailed Description

Hemodialysis is a necessary treatment to prolong the lives of patients with end-stage kidney disease. However, long-term dialysis can lead to fatigue and decreased sleep quality. Acupoint stimulation can regulate meridians and improve physical function. Nevertheless, the effectiveness of low-level laser stimulation on fatigue and sleep quality in hemodialysis patients remains unclear.

This study is designed to use low-level laser stimulation as an intervention measure to evaluate its effectiveness in improving fatigue and sleep quality in hemodialysis patients.

The experimental group will receive low-level laser stimulation on seven acupoints, including Shenmen (HT7), Neiguan (PC6), Hegu (LI4), Zusanli (ST36), Yanglingquan (GB34), Sanyinjiao (SP6), and Taixi (KI3). The stimulation will be administered three times per week for a duration of six weeks. The control group will receive sham low-level laser stimulation on the acupoints, without emitting laser beams.

Before and after each intervention, fatigue will be measured using a visual analog scale for a total of 18 measurements. Additionally, at baseline and at the 2nd, 4th, and 6th weeks, the hemodialysis patients will be assessed using the Fatigue Scale for Hemodialysis Patients, Dialysis Recovery Time Scale, Pittsburgh Sleep Quality Index, Dialysis Symptom Index, and Beck Depression Inventory.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
72
Inclusion Criteria
  1. Adults aged 20 years and above.
  2. Diagnosed with end-stage kidney disease and receiving regular outpatient hemodialysis three times a week for at least three months.
  3. Conscious and capable of communication in Mandarin or Taiwanese (Hokkien).
  4. Willing to participate in this study and have signed the informed consent form.
Exclusion Criteria
  1. Presence of skin lesions or infectious wounds at the acupoint locations.
  2. Taking immunosuppressive medication.
  3. Photosensitivity or sensitivity to light.
  4. Individuals with implanted cardiac pacemakers.
  5. Patients using sleep medication.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
experimental groupAcupoint stimulationThe experimental group will receive low-level laser stimulation on seven acupoints. The stimulation will be administered three times per week for a duration of six weeks.
control groupAcupoint stimulation(placebo)The control group will receive sham low-level laser stimulation on the acupoints, without emitting laser beams.
Primary Outcome Measures
NameTimeMethod
fatigue1Three times per week, for six weeks, totaling 18 sessions.

The fatigue visual analogue scale:The score ranges from 0 to 10 points, with higher scores indicating a higher level of fatigue.

sleepmeasured at baseline and at the 2nd, 4th, and 6th weeks.

Pittsburgh Sleep Quality Index:The total score ranges from 0 to 21 points, with higher scores indicating poorer sleep quality.

fatigue2measured at baseline and at the 2nd, 4th, and 6th weeks.

Fatigue Scale for Hemodialysis Patients:The score ranges from 26 to 104 points, with higher scores indicating a higher level of fatigue.

fatigue3measured at baseline and at the 2nd, 4th, and 6th weeks.

Dialysis recovery time: The recovery time is divided into four intervals, including less than 2 hours, 2-6 hours, 7-12 hours, and greater than 12 hours. This is determined by responses from dialysis patients regarding the time needed for recovery during dialysis treatment.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Taipei Veterans General Hospital

🇨🇳

Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath